CSL is interested in respiratory therapeutics in the areas of Interstitial Lung Diseases (ILD) and Acute Respiratory Distress Syndrome (ARDS).
For ILD‑related research, halting and reversing fibrosis is a key element of interest. For ARDS‑related research, a focus on Community Acquired Pneumonia (CAP) is of key importance.
Approaches of Particular Interest
- Biologics and Antibody Therapeutics will be prioritized
- Cell and Gene Therapies
Developmental Stage
Validation with patient data, biomarkers, and/or in animal models preferable. Ex vivo models (e.g....